Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10018008HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10025249HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10025003HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10049167HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10049171HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10051080HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10051079HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10051081HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10051053HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10049450HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TCGA Plot Options
Drug Information
GeneTERT
DrugBank IDDB12747
Drug NameTertomotide
Target IDBE0002449
UniProt IDO14746
Regulation Type
PubMed IDs17258078
CitationsKokhaei P, Palma M, Hansson L, Osterborg A, Mellstedt H, Choudhury A: Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells. Exp Hematol. 2007 Feb;35(2):297-304.
GroupsInvestigational
Direct Classification
SMILES
Pathways
PharmGKB
ChEMBL